Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 104 Brain Neoplasms 50 Gliosarcoma 48 Glioma 42 Central Nervous System Neoplasms 28 Astrocytoma 27 Melanoma 21 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 8 Ependymoma 7 Recurrence 6 Neoplasms 6 Sarcoma, Ewing 5 Lymphoma 5 Spinal Cord Neoplasms 4 Skin Neoplasms 4 Sarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Colorectal Neoplasms 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Pinealoma 2 Pancreatic Neoplasms 2

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡